Givaudan SA (OTCMKTS:GVDNY – Get Free Report) was the recipient of a large growth in short interest during the month of December. As of December 31st, there was short interest totaling 1,264 shares, a growth of 90.9% from the December 15th total of 662 shares. Based on an average trading volume of 124,186 shares, the days-to-cover ratio is presently 0.0 days. Based on an average trading volume of 124,186 shares, the days-to-cover ratio is presently 0.0 days.
Wall Street Analyst Weigh In
Several equities research analysts recently weighed in on the stock. Barclays upgraded shares of Givaudan from a “hold” rating to a “strong-buy” rating in a research report on Thursday, November 13th. Deutsche Bank Aktiengesellschaft upgraded shares of Givaudan from a “hold” rating to a “buy” rating in a research report on Monday, November 24th. Finally, Jefferies Financial Group upgraded Givaudan from a “hold” rating to a “buy” rating in a research report on Tuesday, November 11th. Two investment analysts have rated the stock with a Strong Buy rating and two have assigned a Buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Strong Buy”.
Get Our Latest Analysis on GVDNY
Givaudan Trading Down 1.0%
About Givaudan
Givaudan is a Swiss-based global company that develops, manufactures and supplies flavors, fragrances and active cosmetic ingredients for a broad range of consumer products. The company’s core activities are organized around creating taste and scent solutions—ranging from fine fragrances and consumer-packaged goods scents to flavor systems for food and beverages and functional ingredients for personal care. Givaudan works with brand owners and manufacturers to design sensory experiences, improve product performance and meet formulation or regulatory requirements.
Its product and service offerings include bespoke fragrance creation, flavor formulation, natural ingredient sourcing, aroma chemicals, taste modulators and application support such as prototyping and sensory testing.
Read More
- Five stocks we like better than Givaudan
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- A U.S. “birthright” claim worth trillions – activated quietly
- Executive Order 14330: Trump’s Biggest Yet
- The Crash Has Already Started (Most Just Don’t See It Yet)
Receive News & Ratings for Givaudan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Givaudan and related companies with MarketBeat.com's FREE daily email newsletter.
